ERCC4 and cancer: To the best of our knowledge, the present study was the first work to comprehensively elucidate whether the studied variants of both ERCC4 and ERCC5 were associated with cancer risk and then to evaluate the credibility of significantly epidemiological evidence using the Venice criteria and FPRP tests.